Sort   by:  
 Page size 
ProteomicsDataset01_HT 1h 8h Gemcitabine IMPRINTS
HT cells were treated with 24uM gemcitabine for 1h and 8h (with 8h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.
ORGANISM(S): Homo Sapiens (human) 
2025-06-12 | PXD054852 | JPOST Repository
ProteomicsDataset03_SUDHL4 1h 8h Gemcitabine IMPRINTS
SUDHL4 cells were treated with 24uM gemcitabine for 1h and 8h (with 8h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.
ORGANISM(S): Homo Sapiens (human) 
2025-06-12 | PXD054854 | JPOST Repository
ProteomicsDataset11_DLBCL clinical sample 1 5h Gemcitabine ITDR
Freshly isolated PBMCs from a R/R DLBCL patient were treated with increasing gemcitabine concentrations (and vehicle control) for 5h, collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labe...
ORGANISM(S): Homo Sapiens (human) 
2025-06-12 | PXD054909 | JPOST Repository
ProteomicsDataset08_SUDHL4 1h 8h low dose 2 Gemcitabine IMPRINTS
SUDHL4 cells were treated with 48nM gemcitabine for 1h and 8h (with 8h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.
ORGANISM(S): Homo Sapiens (human) 
2025-06-12 | PXD055016 | JPOST Repository
ProteomicsDataset05_ OCILY19 1h 8h Gemcitabine IMPRINTS
OCILY19 cells were treated with 48nM gemcitabine for 1h and 8h (with 8h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.
ORGANISM(S): Homo Sapiens (human) 
2025-06-12 | PXD054902 | JPOST Repository
ProteomicsDataset04_SUDHL4 3h 5h Gemcitabine IMPRINTS
SUDHL4 cells were treated with 24uM gemcitabine for 3h and 5h (with 5h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.
ORGANISM(S): Homo Sapiens (human) 
2025-06-12 | PXD054901 | JPOST Repository
ProteomicsDataset10_SUDHL4 5h Gemcitabine ITDR
SUDHL4 cells were treated with increasing gemcitabine concentrations (and vehicle control) for 5h, collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and poo...
ORGANISM(S): Homo Sapiens (human) 
2025-06-12 | PXD054908 | JPOST Repository
ProteomicsDataset09_OCILY19 5h Gemcitabine ITDR
OCILY19 cells were treated with increasing gemcitabine concentrations (and vehicle control) for 5h, collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and po...
ORGANISM(S): Homo Sapiens (human) 
2025-06-12 | PXD054907 | JPOST Repository
ProteomicsDataset06_OCILY19 3h 5h Gemcitabine IMPRINTS
OCILY19 cells were treated with 48nM gemcitabine for 3h and 5h (with 5h vehicle control), collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labeling, offline fractionation and pooling.
ORGANISM(S): Homo Sapiens (human) 
2025-06-12 | PXD054903 | JPOST Repository
ProteomicsDataset12_DLBCL clinical sample 2 5h Gemcitabine ITDR
Freshly isolated PBMCs from a R/R DLBCL patient were treated with increasing gemcitabine concentrations (and vehicle control) for 5h, collected and subjected to CETSA heating, followed by cell lysis, isolation of soluble fraction and sample preparation for MS including digestion, desalting, TMT labe...
ORGANISM(S): Homo Sapiens (human) 
2025-06-12 | PXD054910 | JPOST Repository
Sort   by:  
 Page size